CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation

IL-10: The Master Regulator of Immunity to Infection

(2014) Kevin N. Couper et al.   JOURNAL OF IMMUNOLOGY

Dendritic cells require a systemic type I interferon response to mature and induce CD4+Th1 immunity with poly IC as adjuvant

(2009) M. Paula Longhi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Virus-Encoded Homologs of Cellular Interleukin-10 and Their Control of Host Immune Function

(2009) B. Slobedman et al.   JOURNAL OF VIROLOGY

Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes

(2008) Jacques Thibodeau et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

CD83 on murine APC does not function as a costimulatory receptor for T cells

(2008) B KRETSCHMER et al.   IMMUNOLOGY LETTERS

A captured viral interleukin 10 gene with cellular exon structure

(2008)   JOURNAL OF GENERAL VIROLOGY

Immunomodulatory Properties of a Viral Homolog of Human Interleukin-10 Expressed by Human Cytomegalovirus during the Latent Phase of Infection

(2008) C. Jenkins et al.   JOURNAL OF VIROLOGY

Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells

(2008) Louise J Young et al.   NATURE IMMUNOLOGY

MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation

(2008) A. De Gassart et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

(2008) G. Lenz et al.   SCIENCE

New horizons in adjuvants for vaccine development

(2008) Steven G. Reed et al.   TRENDS IN IMMUNOLOGY

Failed efficacy of soluble human CD83-Ig in allogeneic mixed lymphocyte reactions and experimental autoimmune encephalomyelitis: Implications for a lack of therapeutic potential

(2007) Achal Pashine et al.   IMMUNOLOGY LETTERS

Dendritic cell CD83: A therapeutic target or innocent bystander?

(2007) Charlene M. Prazma et al.   IMMUNOLOGY LETTERS